inj penidure total dose in rpr positive pregnancy in indian guidelines

Reading File

Finding Sources

Searching the Web

benzathine penicillin penidure RPR positive pregnancy Indian guidelines FOGSI total dose syphilis

Searching PubMed

"benzathine penicillin" AND syphilis AND pregnancy AND treatment

Reading File

Excellent - I now have comprehensive data from Indian guidelines (NHSRC/NACO), Park's textbook (Indian PSM reference), WHO, and international MFM references. Here is the complete answer:

Inj. Penidure (Benzathine Penicillin G) in RPR-Positive Pregnancy - Indian Guidelines

Penidure is the trade name for Benzathine Penicillin G (long-acting), and it is the only recommended drug for syphilis treatment in pregnancy in India. No alternatives are safe and equally effective - doxycycline is contraindicated in pregnancy, and erythromycin does not adequately cross the placenta to treat the fetus.

Dosing by Stage (Indian/NACO/NHSRC Guidelines)

Stage	Criteria	Dose	Total Dose
Early Syphilis	Primary, secondary, or early latent (<2 years duration; RPR titre approx. <1:8)	Inj. Penidure 2.4 million IU IM as a single dose	2.4 million IU
Late / Unknown Duration	Tertiary, late latent (>2 years), or unknown duration; RPR titre approx. >1:8	Inj. Penidure 2.4 million IU IM weekly x 3 doses	7.2 million IU

Per NHSRC India's Guidelines for Syphilis Screening during Pregnancy (National programme under Ministry of Health & Family Welfare).

Key Practical Points (Indian Guidelines / Park's PSM)

Test dose mandatory - Administer Inj. Benzathine Penicillin 2.4 million IU IM after test dose with an emergency tray ready (risk of anaphylaxis).
Both buttocks - The 2.4 MU dose is typically split as 1.2 MU into each gluteal muscle.
Second dose consideration - Some experts (and Park's PSM) recommend a second dose of 2.4 MU IM one week after the initial dose even in early syphilis during pregnancy, because treatment failures have been reported. This aligns with CDC/WHO expert opinion.
RPR titre-guided staging - RPR titre <1:8 roughly corresponds to early/primary stage; >1:8 suggests longer duration of infection.
Partner treatment - Sexual partners must also be treated.
Penicillin allergy - Desensitize and treat with penicillin (preferred); if not feasible, use Tab. Erythromycin base/ethyl succinate 500 mg QID x 15 days - but the neonate must be treated after birth as erythromycin does not adequately cross the placenta.

Summary Table (Quick Reference)

	Early Syphilis (<2 yrs / RPR <1:8)	Late/Unknown (>2 yrs / RPR >1:8)
Drug	Inj. Penidure (Benzathine Penicillin G)	Inj. Penidure (Benzathine Penicillin G)
Dose per injection	2.4 million IU IM	2.4 million IU IM
Number of doses	1 (some experts: 2, given 1 week apart)	3 doses, weekly
Total dose	2.4 MU (or 4.8 MU per expert recommendation)	7.2 MU
Route	Intramuscular (1.2 MU each buttock)	Intramuscular

Sources:

NHSRC India - Guidelines for Syphilis Screening during Pregnancy (Ministry of Health & FW)
Park's Textbook of Preventive and Social Medicine, 25th Ed. - Management of pregnant women (STI/RTI section)
Creasy & Resnik's Maternal-Fetal Medicine, 9th Ed., Table 48.8 (CDC-recommended treatment of syphilis in pregnancy)
WHO STI Guidelines - Recommendations 5-8 for pregnant women

Find latest NACO/FOGSI guidance on neonatal syphilis screening and treatment

Reading File

Searching the Web

NACO FOGSI neonatal congenital syphilis screening treatment India guidelines 2023 2024

Searching the Web

NHSRC India neonatal syphilis congenital syphilis RPR newborn treatment benzathine penicillin aqueous

Reading Web Page

neonatal congenital syphilis screening RPR newborn treatment benzathine penicillin aqueous dose

Finding Sources

Reading File

I now have comprehensive data from all key sources - the FOGSI/NACO 2024 guidelines (National Guidelines for Elimination of Vertical Transmission of HIV and Syphilis), NHSRC India guidelines, Red Book AAP 2021, and Harrison's. Here is the complete, structured answer:

Neonatal Syphilis Screening & Treatment - Indian Guidelines (NACO/FOGSI 2024)

Primary source: National Guidelines for Elimination of Vertical Transmission of HIV and Syphilis (2024) - jointly by NACO, FOGSI, IAP, National Neonatology Forum & Ministry of Health & Family Welfare.

Step 1 - Neonatal Screening at Birth

Every newborn of an RPR/VDRL-positive mother must have:

RPR/VDRL test on infant's blood (serum, NOT cord blood - cord blood gives false positives)
Quantitative titer compared to the mother's titer at delivery
Complete physical examination for signs of congenital syphilis

Key trigger: A neonatal RPR/VDRL titre that is 4-fold higher than the mother's titre = congenital syphilis, warrants full workup and curative treatment.

Step 2 - Risk Stratification and Management Algorithm (NACO/FOGSI 2024)

Scenario	Infant Criteria	Workup Required	Treatment
Proven / Probable CS	Abnormal physical exam OR neonatal titre ≥4-fold maternal titre OR positive darkfield/PCR	CSF (VDRL + cell count + protein), CBC, long-bone X-ray, chest X-ray	Curative - Aqueous crystalline penicillin G (see dose below) x 10 days
Possible CS	Normal exam + titre ≤4-fold maternal, AND mother untreated / inadequately treated / treated <4 weeks before delivery	CSF, CBC, long-bone X-ray	Aqueous crystalline penicillin G x 10 days (preferred); or Procaine penicillin G x 10 days; or Benzathine penicillin G single dose only if full workup is normal and follow-up is certain
CS Less Likely	Normal exam + titre ≤4-fold maternal + mother treated ≥4 weeks before delivery but with serologic criteria not fully met	Not recommended	Benzathine penicillin G 50,000 units/kg IM - single dose
CS Unlikely / Prophylactic	Normal exam + titre ≤4-fold maternal + mother adequately treated ≥4 weeks before delivery + documented 4-fold maternal titer decline	None required	Benzathine penicillin G 50,000 units/kg IM - single dose (if follow-up uncertain) OR close serologic monitoring without treatment (if follow-up certain)

Step 3 - Treatment Doses (NACO/FOGSI 2024 + NHSRC India)

Curative Treatment (Confirmed/Probable/Possible Congenital Syphilis)

Drug	Dose	Schedule	Duration
Aqueous crystalline penicillin G (1st choice)	100,000-150,000 units/kg/day	50,000 units/kg/dose IV every 12 hours (first 7 days of life), then every 8 hours thereafter	Total 10 days
Procaine penicillin G (alternative)	50,000 units/kg/dose IM	Single daily dose	10 days

Note: Aqueous IV penicillin G is mandatory if CSF is abnormal - benzathine penicillin does NOT penetrate the blood-brain barrier adequately in neonates.

Prophylactic Treatment (CS Less Likely / CS Unlikely)

Drug	Dose	Schedule
Benzathine penicillin G (Inj. Penidure)	50,000 units/kg body weight	Single IM dose

Important Special Situations (NACO/FOGSI 2024)

Mother treated <30 days before delivery - treatment is considered inadequate regardless of drug used; neonate requires curative treatment.
Mother treated with erythromycin/azithromycin - these do not cross the placenta adequately; neonate must receive curative treatment with aqueous penicillin.
Mother's treatment undocumented or unknown - treat neonate with 10-day aqueous penicillin course.
Symptomatic neonates (snuffles, skin rash on palms/soles, hepatosplenomegaly, periostitis, low birth weight, jaundice, pseudoparalysis) - always give curative 10-day course.

Step 4 - Follow-Up After Treatment

Timepoint	Action
2, 4, 6, 12 months	RPR/VDRL serology + clinical examination
Expected response	Passive maternal IgG should decline and become non-reactive by 6 months in uninfected infants
If titer rises or doesn't fall 4-fold by 6-12 months	Re-evaluate, consider retreatment; CSF examination
Treated infants	Repeat serology every 3 months until non-reactive; if rising titer at any point, re-investigate

Quick Decision Summary (India Context)

Newborn of RPR+ mother
         |
  Perform RPR on infant's serum + Physical exam
         |
  ┌──────────────────────────────────────────┐
  │ Abnormal exam OR titre ≥4x maternal      │ --> CURATIVE: Aqueous Pen G IV x 10 days
  │ (Proven/Probable CS)                     │
  └──────────────────────────────────────────┘
         |
  ┌──────────────────────────────────────────┐
  │ Normal exam + titre ≤4x maternal         │
  │ + Mother inadequately treated            │ --> CURATIVE: Aqueous Pen G IV x 10 days
  │ (Possible CS)                            │
  └──────────────────────────────────────────┘
         |
  ┌──────────────────────────────────────────┐
  │ Normal exam + titre ≤4x maternal         │
  │ + Mother adequately treated ≥4 wks ago   │ --> PROPHYLACTIC: Benzathine Pen G
  │ (CS Less Likely / Unlikely)              │    50,000 units/kg IM single dose
  └──────────────────────────────────────────┘

Sources:

National Guidelines for Elimination of Vertical Transmission of HIV and Syphilis 2024 - NACO/FOGSI/MoHFW India
NHSRC India - Guidelines for Syphilis Screening during Pregnancy
Red Book 2021 (AAP), Table 3.66 - Evaluation and Treatment of Infants up to 1 Month
Harrison's Principles of Internal Medicine 22E - Evaluation and Management of Congenital Syphilis, p. 1479

This is a shared conversation. Sign in to Orris to start your own chat.